GHRS
GH Research PLCstockNASDAQ
Market OpenNov 19, 2026 3:03:14 PM EST
18.18USD-0.384%(-0.07)162,942
Loading…
Loading…
1.25B
Healthcare
Biotechnology
HQ
Dublin, Leinster, Ireland
Previous Close
$18.25
Beta
1.29
52-Week High
$31.44 2026-08-07
52-Week Low
$12.04 2025-12-16
SMA 50
$21.73
SMA 200
$21.73
Avg. Vol 10D
347,614
Avg. Vol 30D
338,433
Avg. Vol 90D
313,727
Relative Vol
0.47
68.68M
50.91M
74.13%
2,079,373
4.08%
6.51
54%/46%
79.50%
72.22%
0.5300%
95,000
5,490
3,915
10,915
GHRS Profile
gh research is a privately-held clinical-stage biopharmaceutical company developing novel therapies for the management of mental illness.
GHRS Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 18.49 | 2026-11-12 | -1.57% | 2.298 |
| 1M | 18.28 | 2026-10-19 | -0.45% | 1.475 |
| 3M | 29.80 | 2026-08-19 | -38.93% | 1.314 |
| 6M | 21.94 | 2026-05-19 | -17.05% | 0.790 |
| 1Y | 14.38 | 2025-11-19 | +26.56% | 1.292 |
| 2Y | 9.61 | 2024-11-19 | +89.37% | — |
| 5Y | 25.81 | 2021-11-19 | -29.49% | 1.037 |
GHRS Stock Summary
GH Research PLC (NASDAQ:GHRS) stock price today is $18.20, and today's volume is 158,831. GHRS is down 0.281% today. The 30 day average volume is 338,433. GHRS market cap is $1.25B with 68.68M shares outstanding.